ShareHope Medicine Statistics

Total Valuation

ShareHope Medicine has a market cap or net worth of TWD 3.95 billion. The enterprise value is 5.00 billion.

Market Cap	3.95B
Enterprise Value	5.00B

Important Dates

The next estimated earnings date is Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	Aug 27, 2024

Share Statistics

ShareHope Medicine has 131.09 million shares outstanding. The number of shares has decreased by -0.13% in one year.

Shares Outstanding	131.09M
Shares Change (YoY)	-0.13%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	1.69%
Float	131.03M

Valuation Ratios

The trailing PE ratio is 26.31.

PE Ratio	26.31
Forward PE	n/a
PS Ratio	0.96
PB Ratio	1.12
P/FCF Ratio	17.20
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.96, with an EV/FCF ratio of 21.79.

EV / Earnings	33.31
EV / Sales	1.22
EV / EBITDA	12.96
EV / EBIT	63.47
EV / FCF	21.79

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.51.

Current Ratio	1.67
Quick Ratio	1.44
Debt / Equity	0.51
Debt / EBITDA	5.23
Debt / FCF	8.82
Interest Coverage	1.45

Financial Efficiency

Return on equity (ROE) is 2.29% and return on invested capital (ROIC) is 0.84%.

Return on Equity (ROE)	2.29%
Return on Assets (ROA)	0.69%
Return on Capital (ROIC)	0.84%
Revenue Per Employee	34.75M
Profits Per Employee	1.27M
Employee Count	118
Asset Turnover	0.57
Inventory Turnover	10.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.72% in the last 52 weeks. The beta is 0.51, so ShareHope Medicine's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-4.72%
50-Day Moving Average	30.27
200-Day Moving Average	30.78
Relative Strength Index (RSI)	45.59
Average Volume (20 Days)	114,473

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ShareHope Medicine had revenue of TWD 4.10 billion and earned 150.06 million in profits. Earnings per share was 1.14.

Revenue	4.10B
Gross Profit	739.70M
Operating Income	79.90M
Pretax Income	142.46M
Net Income	150.06M
EBITDA	262.40M
EBIT	79.90M
Earnings Per Share (EPS)	1.14

Full Income Statement

Balance Sheet

The company has 1.41 billion in cash and 2.02 billion in debt, giving a net cash position of -617.52 million or -4.71 per share.

Cash & Cash Equivalents	1.41B
Total Debt	2.02B
Net Cash	-617.52M
Net Cash Per Share	-4.71
Equity (Book Value)	3.96B
Book Value Per Share	26.89
Working Capital	1.33B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 363.56 million and capital expenditures -134.21 million, giving a free cash flow of 229.36 million.

Operating Cash Flow	363.56M
Capital Expenditures	-134.21M
Free Cash Flow	229.36M
FCF Per Share	1.75

Full Cash Flow Statement

Margins

Gross margin is 18.04%, with operating and profit margins of 1.95% and 3.66%.

Gross Margin	18.04%
Operating Margin	1.95%
Pretax Margin	3.47%
Profit Margin	3.66%
EBITDA Margin	6.40%
EBIT Margin	1.95%
FCF Margin	5.59%

Dividends & Yields

This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 1.28%.

Dividend Per Share	0.38
Dividend Yield	1.28%
Dividend Growth (YoY)	-16.80%
Years of Dividend Growth	5
Payout Ratio	38.38%
Buyback Yield	0.13%
Shareholder Yield	1.40%
Earnings Yield	3.80%
FCF Yield	5.81%

Dividend Details

Stock Splits

The last stock split was on August 27, 2024. It was a forward split with a ratio of 1.040000001.

Last Split Date	Aug 27, 2024
Split Type	Forward
Split Ratio	1.040000001

Scores

ShareHope Medicine has an Altman Z-Score of 1.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.73
Piotroski F-Score	n/a